Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in OCGN — Ocugen, Inc.

CIK 1423053 MIAMI, FL
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$1,198,482
-$3,886,092 QoQ
Shares Held
783,322
-72.1% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 147 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Derivatives in OCGN

reported options exposure · as of Jun 30, 2026
CallValue
$391,221
CallShares
255,700
PutValue
$68,238
PutShares
44,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,151,051,707 across 436 Biotechnology names. OCGN ranks #219 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in OCGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,238 44,600
2026-06-30 $1,198,482 783,322
2026-06-30 $391,221 255,700
2026-03-31 $568,883 314,300
2026-03-31 $102,265 56,500
2026-03-31 $5,084,574 2,809,157
2025-12-31 $1,871,036 1,385,953
2025-12-31 $303,075 224,500
2025-12-31 $61,155 45,300
2025-09-30 $254,769 156,300
2025-09-30 $2,556,183 1,568,211
2025-09-30 $136,594 83,800
2025-06-30 $93,411 96,300
2025-06-30 $87,882 90,600
2025-06-30 $583,953 602,014
2025-03-31 $16,096 22,800
2025-03-31 $41,159 58,300
2025-03-31 $174,571 247,268
2024-12-31 $99,739 123,900
2024-12-31 $114,943 142,787
2024-12-31 $241,339 299,800
2024-09-30 $346,108 348,900
2024-09-30 $130,249 131,300
2024-06-30 $575,515 371,300
2024-06-30 $254,510 164,200
2024-03-31 $613,032 373,800
2024-03-31 $421,808 257,200
2024-03-31 $551 336
2023-12-31 $44,447 77,300
2023-12-31 $265,707 462,100
2023-09-30 $198,680 496,700
2023-09-30 $29,960 74,900
2023-06-30 $280,296 516,200
2023-06-30 $311,314 573,323
2023-06-30 $96,871 178,400
2023-03-31 $301,962 354,000
2023-03-31 $482,371 565,500
2023-03-31 $250,667 293,866
2022-12-31 $1,185,080 911,600
2022-12-31 $386,100 297,000
2022-12-31 $339,720 261,324
2022-09-30 $1,103,244 619,800
2022-09-30 $313,102 175,900
2022-09-30 $424,998 238,763
2022-06-30 $898,466 395,800
2022-06-30 $90,804 40,002
2022-06-30 $521,419 229,700
2022-03-31 $252,453 76,501
2022-03-31 $756,030 229,100
2022-03-31 $2,200,110 666,700